Diabetisches Fußsyndrom

Stephan Morbach; Ralf Lobmann; Michael Eckhard; Eckhard Müller; Heinrich Reike; Alexander Risse; Gerhard Rümenapf; Maximilian Spraul

doi:10.1055/a-0899-0179

Diabetologie und Stoffwechsel, Inhaltsverzeichnis

Diabetologie und Stoffwechsel 2019; 14(S 02): S267-S277
DOI: 10.1055/a-0899-0179

DDG-Praxisempfehlung

Diabetisches Fußsyndrom

Stephan Morbach

¹Abteilung für Diabetologie und Angiologie, Marienkrankenhaus gGmbH, Soest

,

Ralf Lobmann

²Klinik für Endokrinologie, Diabetologie und Geriatrie, Krankenhaus Bad Cannstatt, Klinikum Stuttgart

,

Michael Eckhard

³Universitäres Diabeteszentrum und Interdisziplinäres Zentrum Diabetischer Fuß Mittelhessen, Med. Klinik und Poliklinik III, Universitätsklinikum Gießen und Marburg GmbH, Standort Gießen

,

Eckhard Müller

⁴Schwerpunktpraxis für Diabetologie und Nephrologie, KfH-Nierenzentrum, Bernkastel-Kues

,

Heinrich Reike

⁵Innere Abteilung, Mariannen-Hospital, Werl

,

Alexander Risse

⁶Diabetologie, Medizinische Klinik Nord, Dortmund

,

Gerhard Rümenapf

⁷Oberrheinisches Gefäßzentrum, Klinik für Gefäßchirurgie, Diakonissen-Stiftungs-Krankenhaus, Speyer

,

Maximilian Spraul

⁸Diabetes-Zentrum Rheine, Medizinische Klinik III (Mathias-Spital und Jakobi-Krankenhaus), Rheine

Literatur
1 Claessen H, Narres M, Haastert H. et al. Lower-extremity amputations in people with and without diabetes in Germany, 2008–2012 – an analysis of more than 30 million inhabitants. Clin Epidemiol 2018; 10: 475-488
2 Fedorko L, Bowen JM, Jones W. et al. Hyperbaric Oxygen Therapy Does Not Reduce Indications for Amputation in Patients With Diabetes With Nonhealing Ulcers of the Lower Limb: A Prospective, Double-Blind, Randomized Controlled Clinical Trial. Diabetes Care 2016; 39 (03) 392-399
3 Santema KTB, Stoekenbroek RM, Koelemay MJW. et al. Hyperbaric Oxygen Therapy in the Treatment of Ischemic Lower-Extremity Ulcers in Patients With Diabetes: Results of the DAMO2CLES Multicenter Randomized Clinical Trial. Diabetes Care 2018; 41 (01) 112-119
4 Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004; 20 (Suppl. 01) S90-S95 . Review
5 Lipsky BA, Berendt AR, Deery HG. et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39 (07) 885-910
6 Edmonds M, Lázaro-Martínez JL, Alfayate-García JM. et al. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, doubleblind, randomised, controlled trial. Lancet Diabetes Endocrinol 2018; 6 (03) 186-196
7 Game F, Jeffcoate W, Tarnow L. et al. LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial. Lancet Diabetes Endocrinol 2018; 11: 870-878
8 Lavery LA, Fulmer J, Shebetka KA. et al. The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial. Int Wound J 2014; 5: 554-560
9 THE 2019 IWGDF GUIDELINES. https://iwgdfguidelines.org/guidelines/guidelines/